Non-Ischemic Heart Failure Patients May Benefit From ICD – St. Jude Study
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical's DEFINITE study could influence national Medicare coverage policy for prophylactic ICD implants, which the agency will review following completion of a separate trial (SCD-HeFT) in 2004
You may also be interested in...
Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
St. Jude Medical estimates the worldwide market for high-voltage cardiac rhythm management devices will approach $4.7 bil. by year-end, growing 20% over the 2003 level, based on published peer-reviewed studies and a potentially broader Medicare coverage policy
Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
St. Jude Medical estimates the worldwide market for high-voltage cardiac rhythm management devices will approach $4.7 bil. by year-end, growing 20% over the 2003 level, based on published peer-reviewed studies and a potentially broader Medicare coverage policy
Physio-Control Sales To Be Resuscitated By AED Study, Medtronic Predicts
Results of the Public Access to Defibrillation trial of automatic external defibrillators (AEDs) will help revive revenue growth at Medtronic's slumping Physio-Control unit, the firm says